Mutant of Moloney murine leukemia virus reverse transcriptase exhibits higher resistance to common RT-qPCR inhibitors

Bahram Arezi1, Melissa McCarthy, Holly Hogrefe

  • 1Agilent Technologies, Stratagene Products Division, La Jolla, CA 92037, USA. bahram.arezi@agilent.com

Analytical Biochemistry
|January 27, 2010
PubMed

Related Concept Videos